Patents by Inventor Sietske Kooijman

Sietske Kooijman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240115685
    Abstract: The present invention pertains to the use of conjugated fumonisin (FUM) in a method to protect an animal against FUM induced mycotoxicosis, in particular to protect against a decrease in average daily weight gain, intestinal damage, liver damage and kidney damage as a result of the ingestion of FUM.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 11, 2024
    Applicant: INTERVET INC.
    Inventors: Sietske Kooijman, Ruud Philip Antoon Maria Segers, Maarten Hendrik Witvliet
  • Publication number: 20240024395
    Abstract: The present invention pertains to the use of conjugated T-2 toxin (T2) in a method to protect an animal against T2 induced mycotoxicosis, in particular to protect against a decrease in average daily weight gain, intestinal damage, skin damage and snout damage, thus one or more of these signs of mycotoxicosis induced by T2 as a result of the ingestion of T2.
    Type: Application
    Filed: December 21, 2021
    Publication date: January 25, 2024
    Applicant: INTERVET INC.
    Inventors: Sietske Kooijman, Ruud Philip Antoon Maria Segers, Maarten Hendrik Witvliet
  • Publication number: 20240024496
    Abstract: The present invention pertains to the use of conjugated zearalenone (ZEA) in a method to protect an animal against ZEA induced mycotoxicosis, in particular to protect against decreased weight gain, kidney damage, liver damage and damage to a reproductive organ.
    Type: Application
    Filed: December 21, 2021
    Publication date: January 25, 2024
    Applicant: INTERVET INC.
    Inventors: Sietske Kooijman, Ruud Philip Antoon Maria Segers, Maarten Hendrik Witvliet
  • Publication number: 20240009303
    Abstract: The present invention pertains to a vaccine comprising in combination non-replicating immunogen of porcine circo virus type 2 (PCV2), non-replicating immunogen of Mycoplasma hyopneumoniae and conjugated deoxynivalenol (DON) for protecting swine against an infection with porcine circo virus type 2, an infection with Mycoplasma hyopneumoniae and DON induced mycotoxicosis.
    Type: Application
    Filed: October 28, 2021
    Publication date: January 11, 2024
    Applicant: Intervet Inc.
    Inventors: Sietske Kooijman, Ruud Philip Antoon Maria Segers, Maarten Hendrik Witvliet
  • Publication number: 20220233496
    Abstract: The present invention pertains to the use of conjugated deoxynivalenol (DON) in a method to protect an animal against DON induced mycotoxicosis, in particular to protect against a decrease in average daily weight gain, liver damage, stomach ulcers and/or kidney damage as a result of the ingestion of DON.
    Type: Application
    Filed: July 2, 2020
    Publication date: July 28, 2022
    Applicant: Intervet Inc.
    Inventors: Sietske Kooijman, Rudd Philip Antoon Maria Segers, Mateusz Walczak, Gudrun Koch, Maarten Hendrik Witlvliet